Danny Nordstrom

Associate

San Francisco
danny.nordstrom@lw.com
+1.415.395.8107

PRACTICES

  • Mergers & Acquisitions
  • Private Equity

INDUSTRIES

  • Energy & Infrastructure
  • Healthcare & Life Sciences
  • Technology

BAR QUALIFICATIONS

  • California

EDUCATION

  • JD, Northwestern University School of Law, 2014
    cum laude
  • BA Economics, BS Journalism, University of Kansas, 2011
    summa cum laude

PROFILE

Danny Nordstrom represents clients in complex M&A and other strategic corporate transactions.

Danny advises private equity sponsors, their portfolio companies, and public and private companies on:

  • Mergers, acquisitions, and dispositions
  • Take-privates
  • Joint ventures
  • Carve-outs 
  • Controlling and minority investments
  • Recapitalizations
  • General corporate matters

He applies a commercially focused approach to help clients structure and execute transactions across a range of industries, with a particular focus on the healthcare and life sciences, technology, and energy and infrastructure sectors. 

Danny started his career at Latham in the firm’s London office, where he focused on cross-border capital markets transactions.

EXPERIENCE

Danny’s experience includes representing:

  • A consortium of investors led by Eric Macy and Mike Corbat in the acquisition of Jackson Hole Mountain Resort from the Kemmerer family
  • ArchiMed, a healthcare-focused investment firm, in its US$1.2 billion take-private acquisition of Natus Medical, a medical device company
  • Natus Medical, an ArchiMed portfolio company, in its acquisition of Micromed
  • Goldman Sachs Alternatives in its acquisition of Xpress Wellness from Latticework Capital Management
  • Teachers’ Curriculum Institute in connection with its receipt of a significant equity investment from Francisco Partners
  • Brookfield Infrastructure in the carve-out of certain US natural gas storage assets through the sale by portfolio company Rockpoint of multiple facilities to Enbridge and Spire 
  • Pipedrive, a sales CRM platform, in its sale of a majority interest to Vista Equity Partners 
  • Behrman Capital in the sale of portfolio company ILC Dover, a global engineering and manufacturing company, to New Mountain Capital
  • Neumora, a biotechnology company backed by ARCH Venture Partners, in its initial formation through the acquisition of multiple life sciences companies 
  • Orbital Therapeutics, a biotechnology company backed by ARCH Venture Partners and a16z, in its formation, initial funding, and entry into a collaboration agreement with Beam Therapeutics 
  • Paradigm, a tech-enabled clinical trial platform company backed by ARCH Venture Partners and General Catalyst, in its acquisition of Deep Lens
  • Coherus BioSciences in multiple strategic transactions, including:
    • The divestiture of its Ophthalmology business to Sandoz
    • The divestiture of its YUSIMRY franchise to Meitheal Pharmaceuticals
    • Its acquisition of Surface Oncology
  • Servco Pacific Capital in its controlling investment in Fender Musical Instruments Corporation through the acquisition of shares from TPG Growth
  • Nanosys, an advanced materials manufacturer, in the sale of its quantum dot business to Shoei Chemical
  • Arixa Pharmaceuticals, a developer of oral antibiotics, in its sale to Pfizer 
  • Broadcom in multiple strategic acquisitions
  • Education.com, a venture-backed educational technology company, in its sale to IXL Leaning
  • Gemba Academy, an educational technology company, in its sale of a majority interest to Forum Media Group
  • RapidAI in its acquisition of EndoVantage
  • IMGN Media, a media technology company, in its sale to Warner Music Group
  • A global medical device company in multiple debt and equity investments and strategic corporate transactions